MA40254A - Polymorphes du selinexor - Google Patents
Polymorphes du selinexorInfo
- Publication number
- MA40254A MA40254A MA040254A MA40254A MA40254A MA 40254 A MA40254 A MA 40254A MA 040254 A MA040254 A MA 040254A MA 40254 A MA40254 A MA 40254A MA 40254 A MA40254 A MA 40254A
- Authority
- MA
- Morocco
- Prior art keywords
- selinexor
- polymorphs
- selinexor polymorphs
- Prior art date
Links
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 title 1
- 229950010613 selinexor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462038069P | 2014-08-15 | 2014-08-15 | |
| PCT/US2015/045395 WO2016025904A1 (fr) | 2014-08-15 | 2015-08-14 | Formes polymorphes de selinexor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA40254A true MA40254A (fr) | 2021-05-19 |
| MA40254B1 MA40254B1 (fr) | 2022-09-30 |
Family
ID=53969460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA40254A MA40254B1 (fr) | 2014-08-15 | 2015-08-14 | Polymorphes du selinexor |
Country Status (18)
| Country | Link |
|---|---|
| US (6) | US10519139B2 (fr) |
| EP (2) | EP4112615A1 (fr) |
| JP (3) | JP6777626B2 (fr) |
| KR (1) | KR102608259B1 (fr) |
| CN (3) | CN111484483B (fr) |
| AU (4) | AU2015301484B2 (fr) |
| CA (1) | CA2957266A1 (fr) |
| CO (1) | CO2017001884A2 (fr) |
| DK (1) | DK3180331T3 (fr) |
| EA (1) | EA201790384A1 (fr) |
| ES (1) | ES2926377T3 (fr) |
| IL (1) | IL250328B (fr) |
| MA (1) | MA40254B1 (fr) |
| MX (2) | MX388170B (fr) |
| SG (2) | SG10201808624VA (fr) |
| UA (1) | UA123535C2 (fr) |
| WO (1) | WO2016025904A1 (fr) |
| ZA (1) | ZA201700880B (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2954991T3 (es) | 2011-07-29 | 2023-11-28 | Karyopharm Therapeutics Inc | Moduladores del transporte nuclear que contienen hidrazida y usos de los mismos |
| SMT202000347T1 (it) | 2012-05-09 | 2020-07-08 | Biogen Ma Inc | Modulatori di trasporto nucleare e loro usi |
| WO2014144772A1 (fr) | 2013-03-15 | 2014-09-18 | Karyopharm Therapeutics Inc. | Procédés de promotion de la cicatrisation d'une plaie à l'aide d'inhibiteurs de crm1 |
| PL3010892T3 (pl) | 2013-06-21 | 2019-07-31 | Karyopharm Therapeutics, Inc. | 1,2,4-triazole jako modulatory transportu jądrowego i ich zastosowania |
| CN111484483B (zh) | 2014-08-15 | 2023-05-26 | 卡尔约药物治疗公司 | 赛灵克斯的多晶型物 |
| EP3397634A1 (fr) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Modulateurs de transport nucléaire et leurs utilisations |
| EP3397633A1 (fr) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Modulateurs de transport nucléaire et leurs utilisations |
| US11034675B2 (en) | 2016-01-08 | 2021-06-15 | Dr. Reddy's Laboratories Limited | Solid forms of Selinexor and process for their preparation |
| US11602530B2 (en) | 2016-11-28 | 2023-03-14 | Biogen Ma Inc. | CRM1 inhibitors for treating epilepsy |
| EP3565813A1 (fr) | 2017-01-05 | 2019-11-13 | Watson Laboratories, Inc. | Nouvelles formes cristallines de sélinexor et leur procédé de préparation |
| CN106831731B (zh) * | 2017-01-17 | 2019-11-08 | 广州市闻皓生物科技有限公司 | 一种Selinexor原料药的合成方法 |
| WO2019232724A1 (fr) | 2018-06-06 | 2019-12-12 | Xw Laboratories, Inc. | Composés en tant que modulateurs de transport nucléaire et leurs utilisations |
| WO2020072008A1 (fr) * | 2018-10-04 | 2020-04-09 | Deva Holding Anonim Sirketi | Nouvelles dispersions solides de sélinexor |
| JP2022524741A (ja) | 2019-03-20 | 2022-05-10 | ジョンソン、マッセイ、パブリック、リミテッド、カンパニー | セリネクソールの共結晶形態 |
| CA3135712A1 (fr) * | 2019-05-01 | 2020-11-05 | Brian Clinton AUSTAD | Procede de preparation d'inhibiteurs de xpo1 et intermediaires destines a etre utilises dans la preparation d'inhibiteurs de xpo1 |
| EP3968987A4 (fr) * | 2019-05-16 | 2022-10-26 | Mayo Foundation for Medical Education and Research | Méthodes et substances pour le traitement du cancer |
| EP3808742A1 (fr) | 2019-10-16 | 2021-04-21 | Sandoz AG | Polymorphe de selinexor |
| US20230391754A1 (en) | 2020-10-21 | 2023-12-07 | Karyopharm Therapeutics Inc. | Crystalline form of selinexor |
| CN112679477B (zh) * | 2020-12-17 | 2021-10-26 | 佛山奕安赛医药科技有限公司 | 塞利尼索及其中间体的制备方法 |
| EP4452525A4 (fr) * | 2021-12-20 | 2026-01-07 | Rtx Corp | Amélioration de particules de composites à matrice céramique, son procédé de fabrication et articles la comprenant |
| CN116675677B (zh) * | 2023-08-02 | 2023-09-26 | 中国林业科学研究院林产化学工业研究所 | 一种c8漆酚衍生物及其制备方法和应用 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1017398A (en) | 1911-01-16 | 1912-02-13 | John E Folsom | Telegraph-key. |
| CS229934B2 (en) | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| KR840000529A (ko) | 1981-07-07 | 1984-02-25 | 콘스탄틴 루이스 클레멘트 | 인돌 유도체의 제조방법 |
| US4778796A (en) | 1985-07-19 | 1988-10-18 | Dainippon Pharmaceutical Co., Ltd. | ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same |
| JP3111321B2 (ja) | 1990-02-23 | 2000-11-20 | 武田薬品工業株式会社 | 縮合チアゾール化合物 |
| IL97249A (en) | 1990-02-23 | 1995-01-24 | Takeda Chemical Industries Ltd | Compounds of 7,6,5,4-tetrahydrothiazole] B-5,4 [pyridine and compounds of 5,6-dihydro-H4-pyrrolo] D-3,2 [thiazole, their manufacture, and pharmaceutical compositions including or |
| US5541213A (en) | 1993-06-24 | 1996-07-30 | Eisai Co., Ltd. | Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility |
| US5468353A (en) | 1994-05-05 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Mist suppressant for solvent extraction metal electrowinning |
| BR9509760A (pt) | 1994-11-23 | 1998-06-30 | Neurogen Corp | Composto |
| US20030018025A1 (en) | 1995-06-07 | 2003-01-23 | Neurogen Corporation, Corporation Of The State Of Delaware | Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives: new classes of dopamine receptor subtype specific ligands |
| JPH11513382A (ja) | 1995-10-20 | 1999-11-16 | ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ５員複素環化合物、これらの化合物を含む医薬品、それらの使用及びそれらの調製方法 |
| US6214818B1 (en) | 1996-04-04 | 2001-04-10 | Shionogi & Co., Ltd. | Cephem compounds and pharmaceutical compositions containing the same |
| EP1360901A1 (fr) | 1996-04-25 | 2003-11-12 | Nissan Chemical Industries, Limited | Derivés de la 3-hydroxyacroléine et de la acide acrylique 3-hydroxy substitués en positions 2 and 3 par des groups cycliques avec activité pesticide |
| JP4054992B2 (ja) | 1996-04-25 | 2008-03-05 | 日産化学工業株式会社 | エチレン誘導体および有害生物防除剤 |
| DE19624659A1 (de) | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
| US5994398A (en) | 1996-12-11 | 1999-11-30 | Elan Pharmaceuticals, Inc. | Arylsulfonamides as phospholipase A2 inhibitors |
| JP4416198B2 (ja) | 1997-12-19 | 2010-02-17 | 武田薬品工業株式会社 | アニリド誘導体、その製造法および用途 |
| AU2960599A (en) | 1998-03-30 | 1999-10-18 | Akira Karasawa | Quinazoline derivatives |
| US6743585B2 (en) | 1999-09-16 | 2004-06-01 | Agilent Technologies, Inc. | Methods for preparing conjugates |
| CO5271680A1 (es) | 2000-02-21 | 2003-04-30 | Smithkline Beecham Corp | Compuestos |
| ATE310719T1 (de) | 2000-09-29 | 2005-12-15 | Topotarget Uk Ltd | Carbaminsäurederivate enthaltend eine amidgruppe als hdac-inhibitoren |
| JP3795044B2 (ja) | 2001-09-14 | 2006-07-12 | メシルジーン、インコーポレイテッド | ヒストンデアセチラーゼの阻害剤 |
| AU2003287965A1 (en) | 2002-10-24 | 2004-05-13 | Carex Sa | Modulation of peroxisome proliferator activated receptors activity |
| DE10250743A1 (de) | 2002-10-31 | 2004-05-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
| PL376733A1 (pl) | 2002-11-01 | 2006-01-09 | Takeda Pharmaceutical Company Limited | Środek do zapobiegania lub leczenia neuropatii |
| JP4145230B2 (ja) | 2002-11-01 | 2008-09-03 | 武田薬品工業株式会社 | 神経障害の予防・治療剤 |
| US7342115B2 (en) | 2002-11-08 | 2008-03-11 | Neurogen Corporation | 3-substituted-6-aryl pyridines |
| WO2004076418A1 (fr) | 2003-02-28 | 2004-09-10 | Galderma Research & Development, S.N.C. | Ligands modulant des recepteurs du type lxr |
| CA2566094A1 (fr) | 2004-05-26 | 2005-12-08 | Eisai R & D Management Co., Ltd. | Compose de cinnamide |
| AU2005272389B2 (en) | 2004-08-11 | 2011-08-04 | Kyorin Pharmaceutical Co., Ltd. | Novel cyclic aminobenzoic acid derivative |
| WO2006019020A1 (fr) | 2004-08-16 | 2006-02-23 | Sankyo Company, Limited | Urées de substitution |
| US20100130737A1 (en) | 2005-02-18 | 2010-05-27 | Takeda Pharmaceutical Company Limited | Regulating Agent of GPR34 Receptor Function |
| US8637559B2 (en) | 2005-11-15 | 2014-01-28 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound and pharmaceutical composition |
| JP2007210929A (ja) | 2006-02-09 | 2007-08-23 | Sankyo Co Ltd | ウレア化合物を含有する医薬 |
| PL1992618T3 (pl) | 2006-03-09 | 2012-06-29 | Eisai R&D Man Co Ltd | Policykliczna pochodna cynamidowa |
| WO2007118137A1 (fr) | 2006-04-07 | 2007-10-18 | Methylgene Inc. | Dérivés de benzamide utilisés en tant qu'inhibiteurs de l'histone désacétylase |
| NZ572268A (en) | 2006-04-18 | 2011-09-30 | Nippon Chemiphar Co | Activating agent for peroxisome proliferator activated receptor delta (ppar) |
| JP4999923B2 (ja) | 2006-06-13 | 2012-08-15 | 中国科学院上海薬物研究所 | 複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物 |
| CA2658925C (fr) | 2006-07-27 | 2015-07-14 | Amorepacific Corporation | Nouveaux derives de sulfonylamino acrylamide, isomeres de ceux-ci, ou sels acceptables sur le plan pharmaceutique de ceux-ci utilises en tant qu'antagonistes du recepteur vanilloide, et compositions pharmaceutiquesles contenant |
| JP4388997B2 (ja) | 2006-09-05 | 2009-12-24 | 協和発酵キリン株式会社 | イミダゾール誘導体 |
| EP1939180A1 (fr) | 2006-12-20 | 2008-07-02 | sanofi-aventis | Hétéroarylacrylamides et leur utilisation en tant que médicament pour la stimulation de l'expression de la synthase NO endotheliale |
| EP1942104A1 (fr) | 2006-12-20 | 2008-07-09 | sanofi-aventis | Hétéroarylcyclopropanecarboxamide et leur utilisation pharmaceutique |
| CN101711154A (zh) | 2007-02-26 | 2010-05-19 | 科森生物科学公司 | 氨基甲酸酯化合物 |
| EP2003118A1 (fr) | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Dérivés d'acides de cannelle en tant que modulateurs du récepteur EP2 |
| WO2010017545A2 (fr) | 2008-08-08 | 2010-02-11 | Synta Pharamceuticals Corp. | Composés de triazole qui modulent l'activité hsp90 |
| MX2012000434A (es) | 2009-07-09 | 2012-04-11 | Crescendo Therapeutics Llc | Metodo de sanacion de herida y modulacion de cicatriz. |
| US8518968B2 (en) | 2009-12-04 | 2013-08-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hydrazone and diacyl hydrazine compounds and methods of use |
| CN103002742B (zh) | 2010-03-05 | 2016-07-13 | 卡尔约药物治疗公司 | 核转运调节剂及其应用 |
| JP6106605B2 (ja) | 2011-01-17 | 2017-04-05 | カリオファーム セラピューティクス，インコーポレイテッド | オレフィン含有核輸送調節剤およびその使用 |
| CA2842364A1 (fr) | 2011-07-29 | 2013-02-07 | Karyopharm Therapeutics, Inc. | Modulateurs de transport nucleaire et leurs utilisations |
| ES2954991T3 (es) * | 2011-07-29 | 2023-11-28 | Karyopharm Therapeutics Inc | Moduladores del transporte nuclear que contienen hidrazida y usos de los mismos |
| WO2013020024A2 (fr) | 2011-08-03 | 2013-02-07 | Karyopharm Therapeutics, Inc. | Composés de maléimide et méthodes de traitement |
| SMT202000347T1 (it) | 2012-05-09 | 2020-07-08 | Biogen Ma Inc | Modulatori di trasporto nucleare e loro usi |
| WO2014152263A1 (fr) | 2013-03-15 | 2014-09-25 | Karyopharm Therapeutics Inc. | Modulateurs de transport nucléaire contenant une exo-oléfine et leurs utilisations |
| WO2014144772A1 (fr) | 2013-03-15 | 2014-09-18 | Karyopharm Therapeutics Inc. | Procédés de promotion de la cicatrisation d'une plaie à l'aide d'inhibiteurs de crm1 |
| PL3010892T3 (pl) | 2013-06-21 | 2019-07-31 | Karyopharm Therapeutics, Inc. | 1,2,4-triazole jako modulatory transportu jądrowego i ich zastosowania |
| WO2014205393A1 (fr) | 2013-06-21 | 2014-12-24 | Karyopharm Therapeutics Inc. | Modulateurs de transport nucléaire et leurs utilisations |
| WO2015073908A1 (fr) * | 2013-11-15 | 2015-05-21 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Procédé de sélection d'un schéma de traitement du cancer |
| JP6805137B2 (ja) | 2014-07-11 | 2020-12-23 | アンセルム（アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） | 血液学的癌を診断するための方法 |
| WO2016015598A1 (fr) * | 2014-07-26 | 2016-02-04 | Sunshine Lake Pharma Co., Ltd. | 2-amino-pyrido [2,3-d] pyrimidin -7 (8h)-one utilisés en tant qu'inhibiteurs de cdk et utilisations de ceux-ci |
| CN111484483B (zh) | 2014-08-15 | 2023-05-26 | 卡尔约药物治疗公司 | 赛灵克斯的多晶型物 |
| CN108348547B (zh) | 2015-08-28 | 2023-09-22 | 纽约市哥伦比亚大学信托人 | 用于匹配肿瘤学特征的系统和方法 |
| EP3397634A1 (fr) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Modulateurs de transport nucléaire et leurs utilisations |
| EP3397633A1 (fr) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Modulateurs de transport nucléaire et leurs utilisations |
| US11034675B2 (en) * | 2016-01-08 | 2021-06-15 | Dr. Reddy's Laboratories Limited | Solid forms of Selinexor and process for their preparation |
| JP6765198B2 (ja) | 2016-03-10 | 2020-10-07 | パナソニック株式会社 | 潜熱蓄熱材及びそれを用いる蓄熱システム |
| US11602530B2 (en) | 2016-11-28 | 2023-03-14 | Biogen Ma Inc. | CRM1 inhibitors for treating epilepsy |
| EP3565813A1 (fr) * | 2017-01-05 | 2019-11-13 | Watson Laboratories, Inc. | Nouvelles formes cristallines de sélinexor et leur procédé de préparation |
| CN106831731B (zh) | 2017-01-17 | 2019-11-08 | 广州市闻皓生物科技有限公司 | 一种Selinexor原料药的合成方法 |
| PH12021552349A1 (en) | 2019-03-27 | 2022-09-12 | Karyopharm Therapeutics Inc | Biomarkers for selinexor |
| EP3808742A1 (fr) | 2019-10-16 | 2021-04-21 | Sandoz AG | Polymorphe de selinexor |
| GB2591846B (en) | 2019-12-06 | 2024-08-14 | Bae Systems Plc | Light source |
| US20230391754A1 (en) | 2020-10-21 | 2023-12-07 | Karyopharm Therapeutics Inc. | Crystalline form of selinexor |
-
2015
- 2015-08-14 CN CN202010093491.4A patent/CN111484483B/zh active Active
- 2015-08-14 MA MA40254A patent/MA40254B1/fr unknown
- 2015-08-14 WO PCT/US2015/045395 patent/WO2016025904A1/fr not_active Ceased
- 2015-08-14 AU AU2015301484A patent/AU2015301484B2/en active Active
- 2015-08-14 EA EA201790384A patent/EA201790384A1/ru unknown
- 2015-08-14 SG SG10201808624VA patent/SG10201808624VA/en unknown
- 2015-08-14 EP EP22176543.1A patent/EP4112615A1/fr active Pending
- 2015-08-14 DK DK15754099.8T patent/DK3180331T3/da active
- 2015-08-14 CN CN201580056017.1A patent/CN107072992B/zh active Active
- 2015-08-14 UA UAA201702169A patent/UA123535C2/uk unknown
- 2015-08-14 EP EP15754099.8A patent/EP3180331B1/fr active Active
- 2015-08-14 CA CA2957266A patent/CA2957266A1/fr active Pending
- 2015-08-14 US US15/503,319 patent/US10519139B2/en active Active
- 2015-08-14 MX MX2017002013A patent/MX388170B/es unknown
- 2015-08-14 KR KR1020177006680A patent/KR102608259B1/ko active Active
- 2015-08-14 JP JP2017508087A patent/JP6777626B2/ja active Active
- 2015-08-14 ES ES15754099T patent/ES2926377T3/es active Active
- 2015-08-14 SG SG11201700789SA patent/SG11201700789SA/en unknown
- 2015-08-14 CN CN202010093239.3A patent/CN111481553B/zh active Active
-
2017
- 2017-01-29 IL IL250328A patent/IL250328B/en unknown
- 2017-02-03 ZA ZA2017/00880A patent/ZA201700880B/en unknown
- 2017-02-14 MX MX2021014128A patent/MX2021014128A/es unknown
- 2017-02-24 CO CONC2017/0001884A patent/CO2017001884A2/es unknown
-
2019
- 2019-11-11 US US16/679,630 patent/US11078190B2/en active Active
-
2020
- 2020-05-19 AU AU2020203246A patent/AU2020203246B2/en active Active
- 2020-05-29 JP JP2020093874A patent/JP7218323B2/ja active Active
-
2021
- 2021-07-01 US US17/365,656 patent/US11807629B2/en active Active
- 2021-12-14 AU AU2021286266A patent/AU2021286266B2/en active Active
-
2023
- 2023-01-25 JP JP2023009361A patent/JP7558310B2/ja active Active
- 2023-04-05 US US18/131,273 patent/US11753401B2/en active Active
- 2023-04-07 US US18/132,241 patent/US11746102B2/en active Active
- 2023-07-26 US US18/226,570 patent/US12371420B2/en active Active
-
2024
- 2024-04-30 AU AU2024202835A patent/AU2024202835A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20240044I1 (fi) | Odronekstamabi | |
| NO2023039I1 (no) | Glofitamab | |
| FIC20240035I1 (fi) | Toferseeni | |
| FIC20240015I1 (fi) | Zilbrysq - tsilukoplaani | |
| MA40254A (fr) | Polymorphes du selinexor | |
| DK3183051T3 (da) | Væske-til-luftmembranenergivekslere | |
| LT3134402T (lt) | 4-amino-imidazochinolino junginiai | |
| DK3006072T3 (da) | Karadgang | |
| DK3211743T3 (da) | Ø-til-netværk-omskiftningsfremgangsmåde | |
| DK3222714T3 (da) | Phytasemutanter | |
| DK3119396T3 (da) | Muscarinreceptoragonister | |
| EP3230438C0 (fr) | N-glycosylation | |
| FIC20240047I1 (fi) | Frukintinibi | |
| EP4011484C0 (fr) | Anhydrase carbonique de thermovibrio ammonificans | |
| DK4242916T3 (da) | Forstøver | |
| DK3183340T3 (da) | Termolabile exonukleaser | |
| DE112015001664A5 (de) | Betätigungsaktuator | |
| DK3154703T3 (da) | Fuldkappe-snekkecentrifuge | |
| FR3025617B1 (fr) | Architecture bi-voies | |
| DE112015005041A5 (de) | Gargerätevorrichtung | |
| DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
| DK3110439T3 (da) | Pcsk9-vacciner | |
| DE102014000623A8 (de) | Halbhohlnietelement | |
| DK3009858T3 (da) | Skyradar | |
| DE202014005655U8 (de) | llluminationsvorrichtung |